Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology

por Shimada, Y, Imamura, M, Watanabe, G, Uchida, S, Harada, H, Makino, T, Kano, M
Publicado 1999

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder

por Niehans, G A, Kratzke, R A, Froberg, M K, Aeppli, D M, Nguyen, P L, Geradts, J
Publicado 1999

Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer

por Pujol, P, Daurès, J-P, Brouillet, J-P, Maudelonde, T, Rochefort, H, Grenier, J
Publicado 1999

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado 1999

Patient survival after D (1) and D (2) resections for gastric cancer: long-term results of the MRC randomized surgical trial

por Cuschieri, A, Weeden, S, Fielding, J, Bancewicz, J, Craven, J, Joypaul, V, Sydes, M, Fayers, P
Publicado 1999

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

por Kuhn, W, Schmalfeldt, B, Reuning, U, Pache, L, Berger, U, Ulm, K, Harbeck, N, Späthe, K, Dettmar, P, Höfler, H, Jänicke, F, Schmitt, M, Graeff, H
Publicado 1999

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

por Vathaire, F de, Hawkins, M, Campbell, S, Oberlin, O, Raquin, M-A, Schlienger, J-Y, Shamsaldin, A, Diallo, I, Bell, J, Grimaud, E, Hardiman, C, Lagrange, J-L, Daly-Schveitzer, N, Panis, X, Zucker, J-M, Sancho-Garnier, H, Eschwège, F, Chavaudra, J, Lemerle, J
Publicado 1999

Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer

por Ardizzoni, A, Grossi, F, Scolaro, T, Giudici, S, Foppiano, F, Boni, L, Tixi, L, Cosso, M, Mereu, C, Ratto, G Battista, Vitale, V, Rosso, R
Publicado 1999

Overexpression of IL-1ra gene up-regulates interleukin-1β converting enzyme (ICE) gene expression: possible mechanism underlying IL-1β-resistance of cancer cells

por Sumitomo, M, Tachibana, M, Murai, M, Hayakawa, M, Nakamura, H, Takayanagi, A, Shimizu, N
Publicado 1999

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/A...

por Harrison, C N, Gregory, W, Hudson, G Vaughan, Devereux, S, Goldstone, A H, Hancock, B, Winfield, D, MacMillan, A K, Hoskin, P, Newland, A C, Milligan, D, Linch, D C
Publicado 1999

HPV testing in primary screening of older women

por Cuzick, J, Beverley, E, Ho, L, Terry, G, Sapper, H, Mielzynska, I, Lorincz, A, Chan, W-K, Krausz, T, Soutter, P
Publicado 1999

The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

por Iizuka, N, Hirose, K, Noma, T, Hazama, S, Tangoku, A, Hayashi, H, Abe, T, Yamamoto, K, Oka, M
Publicado 1999

The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells

por Traunecker, H C L, Stevens, M C G, Kerr, D J, Ferry, D R
Publicado 1999

Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma

por Kosmehl, H, Berndt, A, Strassburger, S, Borsi, L, Rousselle, P, Mandel, U, Hyckel, P, Zardi, L, Katenkamp, D
Publicado 1999

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

por Tokuda, Y, Watanabe, T, Omuro, Y, Ando, M, Katsumata, N, Okumura, A, Ohta, M, Fujii, H, Sasaki, Y, Niwa, T
Publicado 1999

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24

por Abel, F, Ejeskär, K, Kogner, P, Martinsson, T
Publicado 1999

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

por Witte, J H de, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, Tienoven, ThH van, Heuvel, J J T M, Vries, J Bolt-De, Benraad, ThJ, Foekens, J A
Publicado 1999

Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma

por Matsumoto, M, Furihata, M, Ishikawa, T, Ohtsuki, Y, Ogoshi, S
Publicado 1999

Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines

por Herring, C J, Deans, B, Elder, R H, Rafferty, J A, MacKinnon, J, Barzilay, G, Hickson, I D, Hendry, J H, Margison, GP
Publicado 1999

Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland

por Rusin, M, Butkiewicz, D, Malusecka, E, Zborek, A, Harasim, J, Czyzewski, K, Bennett, W P, Shields, P G, Weston, A, Welsh, J A, Krzyzowska-Gruca, S, Chorazy, M, Harris, C C
Publicado 1999